Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Molecular characterization of neuroendocrine prostate cancer organoids and PDOX by RNA-seq

ABSTRACT: Molecular characterization of neuroendocrine prostate cancer organoids and PDOX by RNA-seq

PROVIDER: PRJNA449096 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR6956230_1.fastq.gz	Fastqsanger.gz
	SRR6956230_2.fastq.gz	Fastqsanger.gz
	SRR6956231_1.fastq.gz	Fastqsanger.gz
	SRR6956231_2.fastq.gz	Fastqsanger.gz
	SRR6956232_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 18

Similar Datasets

Molecular characterization of neuroendocrine prostate cancer organoids and PDOX by RNA-seq

Project description:We report the generation and characterization of tumor organoids and PDOX derived from needle biopsies of metastatic lesions from neuroendocrine prostate cancer patients.

2018-06-22 | GSE112786 | GEO

Establishment and characterization of prostate cancer organoids

Project description:Establishment and characterization of prostate cancer organoids

| PRJNA454345 | ENA

Establishment and characterization of prostate cancer organoids

Project description:Establishment and characterization of prostate cancer organoids

| PRJNA454346 | ENA

Establishment and characterization of prostate cancer organoids

Project description:Establishment and characterization of prostate cancer organoids

| PRJNA453902 | ENA

Project description:WES of Neuroendocrine Prostate Cancer Organoids & PDOX

| PRJNA449131 | ENA

Molecular Basis of Neuroendocrine Prostate Cancer

Project description:Molecular Basis of Neuroendocrine Prostate Cancer

| PRJNA282856 | ENA

Establishment and characterization of prostate cancer organoids [array]

Project description:Establishment and characterization of prostate cancer organoids [array]

| PRJNA453752 | ENA

Neuroendocrine prostate cancer models

Project description:Neuroendocrine prostate cancer models

| PRJNA449097 | ENA

Post-transcriptional gene regulation by microRNA-194 promotes neuroendocrine transdifferentiation in prostate cancer

Project description:Potent therapeutic inhibition of the androgen receptor (AR) in prostate adenocarcinoma can lead to the emergence of neuroendocrine prostate cancer (NEPC), a phenomenon associated with enhanced cell plasticity. Here, we show that microRNA-194 (miR-194) is a regulator of epithelial-neuroendocrine transdifferentiation. In clinical prostate cancer samples, miR-194 expression and activity were elevated in NEPC and inversely correlated with AR signalling. Over-expression of miR-194 facilitated the emergence of neuroendocrine features in prostate cancer cells, a process mediated by its ability to directly target a suite of genes involved in cell plasticity. One such target gene was FOXA1, which encodes a transcription factor with a vital role in maintaining the prostate epithelial lineage. Importantly, a miR-194 inhibitor blocked epithelial-neuroendocrine transdifferentiation and inhibited the growth of cell lines and patient-derived organoids possessing neuroendocrine features. Overall, our study reveals a post-transcriptional mechanism regulating the plasticity of prostate cancer cells and provides a rationale for targeting miR-194 in NEPC.

2019-09-09 | GSE137071 | GEO

Post-transcriptional gene regulation by microRNA-194 promotes neuroendocrine transdifferentiation in prostate cancer

2019-09-09 | GSE137070 | GEO